Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05790486 · ClinicalTrials.gov registry record · NA

Take A Break - Rural

A NA study of Smoking Cessation and Smoking, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
800
Enrollment target
1
Study location

NCT05790486: Recruiting NA study of Smoking Cessation and Smoking, sponsored by Wake Forest University Health Sciences.

NCT05790486 is a NA study of Smoking Cessation and Smoking that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 800 participants, above the 470-participant average among 188 other Smoking Cessation trials with a reported enrollment target (70% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05790486, a NA study of Smoking Cessation and Smoking, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
1
Study location

Study Summary

The study team proposes a multi-level trial to test 1) novel implementation programs in rural counties designed to increase access to 2) recent advances in tobacco control services for people who are not-yet-ready-to-quit smoking. In this field, most trials have focused only on those already ready-to-quit. Thus, the proposed trial addresses an important knowledge gap critical to advance tobacco control in rural areas.

Primary Outcome

Referral rate of participants by EMS personnel

Interventions

  • BEHAVIORAL Take a Break plus Nicotine replacement therapy (NRT) Sampling
  • BEHAVIORAL The Comparison
  • OTHER Community Paramedicine Standard Plus Enhanced Implementation Program
  • OTHER Community Paramedicine Standard Implementation Program

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2023-07-11
Est. Completion 2026-12
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What NCT05790486 shows while recruiting

NCT05790486 is an interventional study that assigns participants to a tested intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, above the 470-participant average among 188 other Smoking Cessation trials with a reported enrollment target (70% higher).

The record links to 3 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 4 interventions - of which Take a Break plus Nicotine replacement therapy (NRT) Sampling is the first listed.

NCT05790486 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT05790486 about?

NCT05790486 is a clinical study titled "Take A Break - Rural". The study team proposes a multi-level trial to test 1) novel implementation programs in rural counties designed to increase access to 2) recent advances in tobacco control services for people who are not-yet-ready-to-quit smoking. In this field, most trials have focused only on those already ready-t...

What is the current status of trial NCT05790486?

This trial is currently recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2023-07-11. Estimated completion is 2026-12.

What conditions does trial NCT05790486 study?

This clinical trial studies the following conditions: Smoking Cessation, Smoking, Smoking Behaviors.

What interventions are being tested in trial NCT05790486?

The interventions under investigation include: Take a Break plus Nicotine replacement therapy (NRT) Sampling (BEHAVIORAL), The Comparison (BEHAVIORAL), Community Paramedicine Standard Plus Enhanced Implementation Program (OTHER), Community Paramedicine Standard Implementation Program (OTHER).

Who is sponsoring clinical trial NCT05790486?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05790486 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05790486's enrollment target sits among peer trials

800 31st of 188 higher than 158 of 188 other Smoking Cessation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00695214 · 800 participants · Phase 2

    Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea

  • NCT03048201 · 800 participants · NA

    Physica System Total Knee Replacement Registry Study

  • NCT03792659 · 800 participants

    The EXPLORE MG Registry for Myasthenia Gravis

  • NCT03819296 · 800 participants · Phase 1

    Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05790486, the US trial registry maintained by the National Library of Medicine. NCT05790486 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.